Necrosis drives aging and disease by triggering damaging inflammation. Interrupting it may offer new treatments for chronic conditions and improve health in space travel.
Necrosis, a form of uncontrolled cell death, may hold one of the most promising keys to altering the course of human aging, disease, and even space travel, according to a new study by researchers at UCL, the drug discovery company LinkGevity, and the European Space Agency (ESA).
Published in Nature Oncogene, the study brings together an international team of scientists and clinicians to explore how necrosis, when cells die suddenly due to infection, injury, or disease, could transform our understanding and treatment of age-related conditions.
